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Abstract 
Background 
Depression is more likely in patients with chronic physical illness, and is associated with increased rates of 
disability and mortality. Effective treatment of depression may reduce morbidity and mortality. The use of two 
stem questions for case finding in diabetes and coronary heart disease is advocated in the Quality and Outcomes 
Framework, and has become normalised into primary care. 
Aim 
To define the most effective tool for use in consultations to detect depression in people with chronic physical 
illness. 
Design 
Meta-analysis. 
Method 
The following data sources were searched: CENTRAL, CINAHL, Embase, HMIC, MEDLINE, PsycINFO, Web 
of Knowledge, from inception to July 2009. Three authors selected studies that examined identification tools 
and used an interview-based ICD (International Classification of Diseases) or DSM (Diagnostic and statistical 
Manual of Mental Disorders) diagnosis of depression as reference standard. At least two authors independently 
extracted study characteristics and outcome data and assessed methodological quality. 
Results 
A total of 113 studies met the eligibility criteria, providing data on 20 826 participants. It was found that two 
stem questions, PHQ-9 (Patient Health Questionnaire), the Zung, and GHQ-28 (General Health Questionnaire) 
were the optimal measures for case identification, but no method was sufficiently accurate to recommend as a 
definitive case-finding tool. Limitations were the moderate-to-high heterogeneity for most scales and the facts 
that few studies used ICD diagnoses as the reference standard, and that a variety of methods were used to 
determine DSM diagnoses. 
Conclusion 
Assessing both validity and ease of use, the two stem questions are the preferred method. However, clinicians 
should not rely on the two-questions approach alone, but should be confident to engage in a more detailed 
clinical assessment of patients who score positively. 
Keywords: depression, diagnosis, meta-analysis, primary care 
 
INTRODUCTION 
Depression is one of the leading causes of disability and disease burden.1 It is associated with the most years lost 
to disability of all diseases worldwide. Identifying depression in patients with chronic physical health problems 
is important for several reasons. First, a number of studies suggest depression is approximately two to three 
times as prevalent in such populations, including patients with cancer,2 chronic heart disease,3,4 and chronic 
obstructive pulmonary disease (COPD).5 Secondly, there appears to be greater disease burden, in terms of 
healthcare use and functional disability, in people with comorbid depression compared with those with physical 
health problems alone.6,7 Thirdly, mortality is greater in several medical conditions when depression is present 
— heart disease,8 COPD,9 stroke,10 cancer11 — and in medically ill older adults.12 Furthermore, morbidity and 
mortality may diminish with effective treatment of depression.13,14 
There is convincing evidence that many cases of depression go unrecognised in the general population and in 
primary care.15–17 Reasons for under-recognition include a low rate of mood problems as the presenting 
complaint, infrequent specific enquiry from clinicians, and uncertainty about diagnostic criteria.18,19 Identifying 
depression in people with chronic physical health problems may be even more complex, and primary care 
physicians may be less likely to diagnose depression in this population.20,21 Reasons for difficulties in raising the 
issue of depression in consultations are complex.22 In addition, depressed individuals presenting with somatic 
complaints are less likely to be detected.23–26 
Improving case identification for depression has received much attention. For example, the US Preventive 
Services Task Force recommended screening for depression for all people in primary care (whether they had a 
physical illness or not), along with the necessary treatment resources for those subsequently identified.27 In the 
UK, through the Quality and Outcomes Framework (QOF), GPs are incentivised to ask the case-identification 
questions of people with diabetes and coronary heart disease.28 This approach is also advocated in the National 
Institute for Health and Clinical Excellence (NICE) guidelines.29 However, there is much debate in the literature 
concerning the effectiveness of screening and case identification.30 Gilbody and colleagues have shown 
untargeted screening was not effective in improving the recognition of depression in primary care and general 
hospital settings.30 There is also much debate concerning the terminology used in the field. The present study 
proposes to separate overall accuracy (case identification) into more clinically understandable rule-in and rule-
out performance. Rule-in accuracy (positive predictive value) is the ability to correctly identify those with the 
disorder with minimal false positives, whereas rule-out accuracy (negative predictive value) is the ability to 
correctly identify those without the disorder with minimal false negatives (missed cases). In order to 
differentiate from untargeted screening approaches, which appear to be ineffective, this data synthesis will focus 
on case identification in a population at higher risk of depression (that is, people with chronic physical health 
problems). This is vital before further case finding is advocated by the QOF for patients with other physical 
problems. 
How this fits in 
There is strong evidence that the prevalence of depression is raised among patients with long-term conditions 
and that this comorbidity is associated with adverse outcomes. Inadequate and inaccurate identification of 
depression has been documented in both primary care and general medical settings. This meta-analysis provides 
evidence that several brief and feasible depression case-finding approaches can be used as a first assessment for 
patients with chronic physical health problems, and that two stem questions referring to core depression features 
appear the most efficient initial approach. 
There are a large number of scales used both in clinical practice and in research studies, few of which have been 
originally developed for the physically ill. In addition, there are no existing definitive meta-analyses across a 
comprehensive range of measures. Therefore, a diagnostic accuracy meta-analysis was conducted to assess the 
sensitivity and specificity of the most widely used case-identification instruments in people who are physically 
ill. 
METHOD 
Data sources and searches 
The full review protocol can be found in the guideline on depression in people with chronic physical health 
problems, which was commissioned by NICE.31 Briefly, a search for studies assessing the validity of case-
identification instruments was made using seven electronic bibliographic databases (CENTRAL, CINAHL, 
Embase, HMIC, MEDLINE, PsycINFO, Web of Knowledge). Each database was searched from inception to 
October 2009. Additional papers were found by searching the references of retrieved articles, tables of contents 
of relevant journals, previous systematic reviews and meta-analyses of case identification for depression, written 
requests to experts, and suggestions made by the members of the Guideline Development Group (comprising 
clinicians, academics, and service users with expertise in depression and chronic physical health problems). 
 
Study selection 
The study included validation studies of mood questionnaires agreed by the authors (see Appendix 1 for further 
details). The reference standard was diagnoses according to the Diagnostic and Statistical Manual of Mental 
Disorders (DSM) of the American Psychiatric Association (for example DSM-IV)32 or International 
Classification of Diseases (ICD) (for example ICD-10)33 of the World Health Organization criteria. Studies that 
did not clearly state the comparator to be DSM or ICD diagnosis of depression, or that did not provide sufficient 
data to be extracted in the meta-analysis were excluded. 
 
Data extraction and quality assessment 
All published studies that met the eligibility criteria were assessed for methodological quality using the Scottish 
Intercollegiate Guidelines Network (SIGN) checklist for diagnostic studies.29 Data were extracted independently 
by at least two authors, and 2×2 tables were constructed, from which the primary outcomes were calculated: that 
is sensitivity, specificity, and likelihood ratios. 
To maximise the available data, the most consistently reported and recommended cut-off points were extracted 
for each of the scales. There are limitations to this approach, as noted by Furukawa and colleagues,34 ;who found 
that the optimal cut-offs for the General Health Questionnaire (GHQ)-12 and GHQ-28 differed according to the 
prevalence of depression, and it is likely there are similar problems for most other scales. However, a Bayesian 
approach makes allowance for variations according to prevalence (see below), therefore seeking to take into 
account this potential limitation. 
Data synthesis and analysis 
A bivariate diagnostic accuracy meta-analysis was conducted using Stata (version 10) with the metandi35 
commands, to obtain pooled estimates of sensitivity, specificity, and likelihood ratios. This method was 
originally developed as a mixed effects regression model for meta-analysis of trials, and modified more recently 
for studies of diagnostic accuracy.36,37 Between-study heterogeneity was assessed using the I2 statistic.38 In 
addition, publication bias was assessed by visual inspection of funnel plots, and formal use of Egger's test.39 
A Bayesian curve analysis was also undertaken; this plots post-test conditional probabilities from all possible 
pre-test probabilities (prevalence). The area under the Bayesian curve (AUC) for positive results can be used as 
a statistical comparison of rule-in success and 1 — AUC for negatives results used as an indicator of rule-out 
success. An area of more than 0.75 can be interpreted as ‘satisfactory’ and more than 0.80 interpreted as ‘good’. 
If a test achieved more than 0.90 in a rule-in capacity, this was considered sufficient for a recommendation that 
this tool could be used on its own for case finding. 
Additional meta-regression analyses were planned to assess differences in diagnostic accuracy for disease 
groups. Such analyses were conducted on a scale when there were a minimum of four studies for at least two 
disease groups. 
RESULTS 
A total of 113 studies on 20 826 participants met the eligibility criteria of the review (see Figure 1 for full details 
on study flow information). These studies were both on populations specifically targeted for a chronic physical 
health problem (such as cancer, heart disease, and stroke), and in general medical settings where all were 
physically ill and a substantial proportion had a chronic physical health problem. In total, 83 studies specifically 
targeted people with chronic physical health problems in any setting (Appendix 2). The mean prevalence of 
depression was 0.25 (95% confidence interval  CI] = 0.05 to 0.61). A further 30 studies were on people in 
general medical settings, with a mean prevalence of depression of 0.24 (95% CI = 0.04 to 0.52). 
 
Figure 1. Study flow diagram. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Studies recruiting for chronic physical health problem 
Sensitivity and specificity  
Table 1 provides an evidence summary for the various scales on people recruited for specific chronic physical 
health problems. There was moderate to high sensitivity for most scales. The tools with the highest sensitivity 
Potentially relevant papers identified  
by research (n = 28 586) 
Papers retrieved for more detailed  
evaluation (n = 355) 
Papers excluded (n = 242) 
• Data not extractable or outcomes not relevant (n = 76) 
• Population not relevant (n = 74) 
• Reference standard not relevant (n = 56) 
• Scale not relevant (n = 36) 
Papers retrieved because clearly 
not relevant (n = 28 231) 
Studies included 
(n = 113) 
were the two stem questions (0.98; 95% CI = 0.85 to 0.99), followed by the GHQ-28, Patient Health 
Questionnaire (PHQ)-9, Beck Depression Inventory (BDI), and BDI non-somatic (Table 1). Sensitivity was 
lowest for the one-item measure. 
 
Table 1. Evidence summary of scales in studies recruiting for chronic physical illness 
 
Instrument Total 
sample 
size 
(studies) 
Sensitivity 
(95%CI) 
Specificity 
(95%CI) 
Positive LR 
(95%CI) 
Negative LR 
(95%CI) 
I2,% Prevalence 
Patient Health Questionnaire-9 1617 (6) 0.84  
(0.69 to 0.92) 
0.88  
(0.83 to 0.91) 
6.77  
(4.96 to 9.24) 
0.19  
(0.10 to 0.37) 
93 0.26 
Two stem questions     
(low mood and loss of interest) 
1860 (6) 0.98  
(0.85 to 0.99) 
0.86  
(0.70 to 0.94) 
6.81  
(2.98 to 15.57) 
0.02  
(0.002 to 0.21) 
0 0.20 
 
Beck Depression Inventory (BDI) 3486 (22) 0.83  
(0.79 to 0.87) 
0.79  
(0.74 to 0.84) 
3.96  
(3.12 to 5.03) 
0.21  
(0.16 to 0.27) 
90 0.20 
BDI-non somatic items 946 (8)  0.83  
(0.68 to 0.92) 
0.79  
(0.70 to 0.85) 
3.89  
(2.66 to 5.69) 
0.22  
(0.11 to 0.44) 
87 0.22 
Center of Epidemiological 
Studies - Depression 
1812 (11) 0.77  
(0.71 to 0.85) 
0.85  
(0.80 to 0.90) 
5.25  
(3.60 to 7.65) 
0.27  
(0.21 to 0.36) 
0 0.23 
Geriatric Depression Scale   30 687 (13) 0.79  
(0.73 to 0.84) 
0.73  
(0.67 to 0.79) 
2.95  
(2.37 to 3.68) 
0.29  
(0.22 to 0.38) 
0 0.28 
Geriatric Depression Scale-15  823 (8) 0.84  
(0.78 to 0.88) 
0.77  
(0.73 to 0.81) 
3.70  
(3.03 to 4.52) 
0.21  
(0.16 to 0.28) 
0 0.29 
One item    1940 (11) 0.73  
(0.60 to 0.83) 
0.77  
(0.62 to 0.88) 
3.21  
(1.98 to 5.21) 
0.35  
(0.24 to 0.49) 
98  0.26 
General Health Questionnaire-12    517 (5) 0.81  
(0.70 to 0.89) 
0.64  
(0.52 to 0.75) 
2.27  
(1.68 to 3.09) 
0.29  
(0.19 to 0.47) 
53 0.16 
General Health Questionnaire-28    465 (5) 0.90  
(0.79 to 0.96) 
0.80  
(0.62 to 0.90) 
4.39  
(2.31 to 8.35) 
0.13  
(0.06 to 0.25) 
94 0.33 
Hospital Anxiety and Depression 
Scale - Depression 
5087 (29) 0.75  
(0.67 to 0.81) 
0.81  
(0.74 to 0.86) 
3.90  
(2.94 to 5.17) 
0.31  
(0.24 to 0.41) 
99 0.26 
Hamilton Depression Rating 
Scale  
985 (11) 0.81  
(0.75 to 0.86) 
0.85  
(0.76 to 0.91) 
5.32  
(3.24 to 8.71) 
0.22  
(0.16 to 0.31) 
52 0.26 
Zung Self Rating Depression 
Scale  
190 (4) 0.78  
(0.56 to 0.91) 
0.92  
(0.68 to 0.98) 
9.82  
(2.31 to 41.63) 
9 0.24  
(0.11 to 0.50) 
83 0.30 
LR = likelihood ratio. 
The Zung Self Rating Depression Scale had the highest specificity 0.92 (95% CI = 0.68 to 0.98). This was 
followed by the two stem questions, the Hamilton Depression Rating Scale (HDRS), PHQ-9 and the Centre for 
Epidemiologic Studies Depression Scale (CES-D); all had high specificity. The lowest specificity was found for 
the one-item measure and the GHQ-12. 
Rule-in (positive predictive value) and rule-out accuracy (negative predictive value)  
Using Bayesian plots of conditional probabilities to examine rule-in and rule-out performance, only three tools 
had less than satisfactory rule-in performance, namely the single question: the Geriatric Depression Scale (GDS-
30) and GHQ-12. The optimal single tool was the Zung, although it did not reach the a priori standard for 
recommendation when applied alone. For rule-out performance, four methods were not satisfactory. These were 
the single queston, the Hospital Anxiety and Depression Scale (HADS), GDS-30, and GHQ-12. The optimal 
tools were the two stem questions and GHQ-28. Overall accuracy was best for the two stem questions, Zung, 
PHQ-9, and GHQ-28. However, it should be noted that data for the Zung scale were based on just four studies 
and a relatively small total sample size (n = 190). 
Meta-regression comparing the diagnostic accuracy for different disease groups was only possible for the BDI 
and HADS-D. There was no evidence of difference in sensitivity (beta = 0.93, P = 0.34) and specificity (beta = 
1.56, P = 0.35) of the HADS between stroke and cancer patients. There was no evidence of difference in 
sensitivity (beta = 1.49, P = 0.60), but some evidence for differences in specificity (beta = 1.20, P = 0.02) of the 
BDI between heart disease and cancer patients. 
Studies in general medical settings 
Table 2 summarises the results for general medical settings. There were only three scales that provided 
sufficient data for analyses. All these scales performed equally well in this setting as compared to populations 
specifically targeted for chronic physical health problems with a large overlap in confidence intervals. 
 
Table 2 Evidence summary of scales in general medical settings 
 
Instrument Total sample 
size 
(studies) 
Sensitivity 
(95%CI) 
Specificity 
(95%CI) 
Positive LR 
(95%CI) 
Negative LR 
(95%CI) 
/2, % Prevalence 
Geriatric Depression Scale-30 1255 (9) 0.85  
(0.78 to 0.90) 
0.76  
(0.68 to 0.83) 
3.55  
(2.73 to 4.60) 
0.20  
(0.15 to 0.27) 
98  0.36 
Geriatric Depression Scale-15 1108 (8) 0.89  
(0.84 to 0.92) 
0.74  
(0.67 to 0.80) 
3.38  
(2.65 to 4.31) 
0.15  
(0.11 to 0.22) 
63  
 
0.24 
Hospital Anxiety and 
Depression Scale - Depression 
2506 (6) 0.81  
(0.73 to 0.87) 
0.75  
(0.70 to 0.79) 
3.22  
(2.79 to 3.72) 
0.25  
(0.18 to 0.36) 
89 0.15 
LR= likelihood ratio 
 
Sensitivity and specificity  
Sensitivity was relatively high in all measures but particularly high in the GDS-15 (0.89; 95% CI = 0.84 to 
0.92). Specificity was very similar for the GDS-30, GDS-15, and HADS when used in general medical settings 
(Table 2). 
 
Rule-in and rule-out accuracy  
Using the same methodology for each measure in general medical settings and correcting for prevalence using a 
Bayesian analysis, the GDS-15 was most successful and the HADS least successful. No method came close to 
the a priori; standard for rule-in performance when applied alone. For rule-out accuracy, the HADS was 
significantly less accurate than the GDS-15 (Area HADS = 0.71, 95% CI = 0.68 to 0.74 versus Area GDS-15 = 
0.78, 95% CI = 0.75 to 0.82). 
 
DISCUSSION 
Most of the scales performed adequately as case-identification measures for depression, with modest differences 
in validity coefficients. Most studies targeted chronic physically ill populations rather than general medical 
settings such as primary care. In order to detect depression in those with chronic physically ill health, the most 
sensitive instruments appear to be two stem questions, PHQ-9, and GHQ-28. The most specific measure was the 
Zung. Overall, optimal accuracy was achieved by the two stem questions, Zung, PHQ-9, and GHQ-28. 
However, it should be noted that estimates on the Zung and GHQ-28 analysis were based on a relatively small 
sample size; therefore, it is possible that conclusions regarding these scales may change with further data. No 
method came close to the a priori standard for case-finding recommendation when applied alone. 
Another important factor to consider when comparing the different measures is the ease of implementation. The 
Zung is a 20-item scale and therefore is more resource intensive and less likely to be implemented in primary 
care compared to shorter measures. Taking into account both the psychometric properties and ease of 
implementation, it would appear the two stem questions may be the preferred measure for case identification in 
patients with chronic physical health problems. From these data, the authors do not recommend relying upon a 
single question alone, and recommend two questions as a minimum initial enquiry. This is consistent with 
previous pooled data in primary care40 and cancer settings.41 
In general medical settings, there were fewer studies, and analysable data were only available for the GDS, 
GDS-15, and HADS-D. Specificity was similar for all three scales but sensitivity was highest in the GDS-15. 
Further research is needed to confirm whether the optimal tools in the chronically ill (two stem questions, PHQ-
9, and the Zung) perform equally well in general medical samples. 
There are several limitations to the results of this systematic review. First, there was moderate to high 
heterogeneity for most measures. Secondly, there is a paucity of validity studies using the ICD-10 as the 
criterion standard compared with the DSM-IV, which may favour tools using DSM items, and therefore the 
authors recommend future examination using this outcome. Thirdly, there were widely used or potentially useful 
scales that had few or no studies in the physically ill; these include the Montgomery–Asberg Depression Scale 
(MADRS),42 and the Clinically Useful Outcome Depression Scale (CUDOS).43 Further research is needed on 
these scales for people with chronic physical health problems. Fourthly, there were a number of different semi-
structured methods used to determine the interview-based diagnosis, including the Schedules for Clinical 
Assessment in Neuropsychiatry (SCAN),44 the Composite International Diagnostic Interview (CIDI),45 the 
Structured and Clinical Interview for DSM-III-R (SCID),46 and the Diagnostic Interview schedule (DIS),47 all of 
which may vary in diagnostic accuracy. A further limitation is the lack of cost-effectiveness analyses assessing 
the cost impact of false positives associated with the use of case-identification measures. However, it should be 
noted that the cost-effectiveness of case identification is very complex to model and requires a number of 
assumptions concerning probabilities assigned to events in the depression treatment care pathway, and explicit 
values of treatment outcomes.48 Therefore, such issues were considered beyond the scope of this paper. 
It should also be acknowledged that the use of case-identification tools may not be translated into real benefit in 
clinical practice. Case identification may bring limited benefit if there are no effective assessment and treatment 
services in place, as professionals may be reluctant to make a diagnosis of depression if they have limited 
resources on which to call.49 The aim of the NICE guideline for which this review was conducted,31 is to 
promote the commissioning of such services. The impact of case finding on the individual consultation may be 
important, since the use of the PHQ-9 severity questionnaire can cause a tension within the consultation, with 
GPs struggling to manage formal assessment versus personal enquiry.50 
From this data synthesis, it appears that there are a number of instruments for the case identification of 
depression in the medically ill that have similar accuracy. A consideration of both accuracy and acceptability 
suggests that the two stem questions may be the most efficient initial method, although further validation is 
needed. We do not recommend the use of a single question used alone. GPs and practice nurses should not rely 
on the case-finding questions alone; they should be confident to complete an assessment of the patient's mental 
state and risk, and a pathway within the practice should be in place (particularly when it is the practice nurse 
who has done the case finding). Resources within the practice should be available to support patients who have 
depression and a chronic physical health problem, and primary care practitioners should have well-defined links 
with local primary care mental health services, which should offer appropriate interventions for such patients, 
including a collaborative care approach as recommended by NICE.31 
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Appendix 1. Full list of instruments considered 
1. Beck Depression Inventory (BDI):  BDI-II51  BDI Cognitive-Affective scale51  BDI Fast Screen52 
2. Patient Health Questionnaire (PHQ):  PHQ-953  PHQ-254 
3. Two stem questions:55  These are similar to the PHQ-2 except that the scoring system is dichotomous (‘yes’ or ‘no’) rather than 
the Likert scale used for both PHQ-9 and PHQ-2, and the period of reported low mood or loss of interest 
is 1 month rather than 2 weeks 
4. General Health Questionnaire:56  GHQ-12  GHQ-28 
5. Centre of Epidemiological Studies - Depression (CES-D)57 
6. Geriatric Depression Scale (GDS)  GDS-3058  GDS-1559 
7. Zung Self Rating Depression Scale60 
8. Hospital Anxiety and Depression Scale - Depression61 
9. Hamilton Depression Rating Scale HDRS62  Both 17– and 21-item versions 
10. Montgomery-Asberg Depression Rating Scale (MADRS)63 
11. Clinically Useful Depression Outcome Scale64 
12. One-item measures of depression 
13. Edinburgh Postnatal Depression Scale178 
  
Appendix 2 
Summary characteristics of included studies 
Study Country Patients Female 
Mean age, 
years 
Physical health condition Instrument 
Aben et al, 200265 Netherlands 171 91 68 Stroke BDI 
      
HADS-D 
      
HDRS 
 
Agrell and Dehlin, 198966 Sweden 40 22 80 Stroke CES-D 
      
GDS 
      
HDRS 
      
Zung 
 
Akechi et al, 200667 Japan 205 68 61 Cancer 1-item 
      
Two stem questions 
 
Akizuki et al, 200368 Japan 275 164 52 Cancer HADS-D 
      
1-item 
 
Aydin and Ulusahin, 200169 Turkey 100 
Not 
reported 
Not reported Tuberculosis and COPD GHQ-12 
 
Berard et al, 199870 South Africa 100 87 50 Cancer HADS-D 
      
BDI 
 
Berg et al, 200971 Finland 100 32 55 Stroke BDI, HDRS 
 
Blank et al, 200472 US 125 
Not 
reported 
77 Various (general medical) GDS 
      
GDS-15 
      
CES-D 
      
Two stem questions 
 
Burke et al, 199273 US 67 44 77 Various (general medical) GDS 
 
Chilcot et al, 200874 UK 41 16 53 Dialysis BDI 
 
Chochinov et al, 199775 US 197 103 Not reported Cancer Two stem questions 
 
Costantini et al, 199976 Italy 132 132 53 Breast cancer HADS-D 
 
Craven et al, 198877 Canada 99 36 51 Renal dialysis BDI 
 
Cullum et al, 200678 UK 618 371 80 Medically ill (general medical) GDS-15 
 
Diez-Quevedo et al, 200179 Spain 1003 451 43 Medically ill (general medical) PHQ-9 
 
Ertan et al, 200580 Turkey 109 36 67 Parkinson's Disease GDS 
 
Forkman et al, 200981 Germany 126 37 51 Heart disease BDI 
      
BDI-non somatic 
 
Freedland et al, 200382 US 682 327 66 Congestive heart failure BDI 
 
Furlanetto et al, 200583 US 155 98 50 Medically ill (general medical) BDI non-somatic 
Study Country Patients Female 
Mean age, 
years 
Physical health condition Instrument 
items 
 
Galaria et al, 200084 US 70 41 77 Visual impairment GDS 
      
GDS-15 
 
Gilley and Wilson, 199785 US 93 42 70 Medically ill (general medical) GDS 
 
Golden et al, 200786 US 88 23 Not reported Hepatitis C BDI 
      
BDI non somatic 
items 
      
HADS-D 
 
Grassi et al, 200987 Italy 109 83 55 Cancer HADS-D 
 
Hahn et al, 200688 Germany 204 98 50 Medically ill (general medical) GHQ-12 
      
HADS-D 
 
Hall et al, 199989 UK 266 266 Not reported Breast cancer HADS-D 
 
Hammer et al, 200890 US 39 19 58 Amyotrophic lateral sclerosis BDI 
 
Harter et al, 200691 Germany 206 103 48 Musculoskeletal diseases GHQ-12 
      
HADS-D 
 
Harter et al, 200192 Germany 569 285 54 Medically ill (general medical) GHQ-12 
      
HADS-D 
 
Haughey et al, 200593 US 226 226 40 Medically ill (general medical) Two stem questions 
 
Haworth et al, 200794 US 88 15 70 Heart failure GDS-15 
      
HADS-D 
 
Healey et al, 200895 UK 49 28 79 Stroke BDI non-somatic 
 
Hedayati et al, 200696 US 98 44 57 Haemodialysis CES-D 
      
BDI 
 
Hermanns et al, 200697 Germany 376 148 52 Diabetes BDI 
      
CES-D 
 
Herrero et al, 200398 Spain 385 181 38 Medically ill (general medical) HADS-D 
 
Hickie et al, 198799 US 39 
Not 
reported 
Not reported Medically ill (general medical) GDS 
 
Hopko et al, 2007100 US 33 25 54 Cancer HAM-D 
      
BDI 
      
CES-D 
 
Hoyl et al, 1999101 US 74 2 74 Medically ill (general medical) GDS-15 
 
Hughson et al, 1988102 UK 75 75 51 Cancer GHQ-28 
 
Ibbotson et al, 1994103 UK 513 282 Not reported Cancer HADS-D 
      
GHQ-28 
 
Jackson and Baldwin, US 59 Not 77 Medically ill (general medical) GDS 
Study Country Patients Female 
Mean age, 
years 
Physical health condition Instrument 
1993104 reported 
      
GDS-15 
 
Jefford et al, 2004105 US 100 
Not 
reported 
Not reported Cancer 1-item 
 
Johnson et al, 1995106 Australia 204 
Not 
reported 
71 Stroke GDS 
      
HADS-D 
      
GHQ-28 
 
Katz et al, 2004107 Canada 60 13 61 Cancer BDI 
      
HADS-D 
      
CES-D 
 
Kawase et al, 2006108 Japan 305 
Not 
reported 
62 Cancer 1-item 
 
Koenig et al, 1992109 US 109 0 74 Medically ill (general medical) GDS 
      
GDS-15 
 
Kugaya et al, 1998110 Japan 128 48 61 Cancer HADS-D 
 
Lam et al, 2004111 Hong Kong 100 56 69 Medically ill (general medical) HADS 
 
Lamers et al, 2008112 Netherlands 713 350 71 Medically ill (general medical) PHQ-9 
 
Laska et al, 2007113 Sweden 89 40 74 Stroke MADRS 
 
LeFevre et al, 1999114 UK 79 35 70 Cancer HADS-D 
 
Lee et al, 2008115 China 253 94 Not reported Stroke GDS-15 
 
Leentjens et al, 2000116 Netherlands 53 
Not 
reported 
67 Parkinson's disease BDI 
      
HDRS 
      
MADRS 
 
Leung et al, 1998117 Taiwan 50 
Not 
reported 
54 Chronic medical disorders Zung 
 
Lightbody et al, 2007118 UK 28 
Not 
reported 
72 Stroke MADRS 
 
Lincoln et al, 2003119 UK 143 70 66 Stroke BDI 
      
GHQ-28 
 
Lloyd-Williams et al, 2000120 UK 100 56 57 Cancer EPDS 
      
1-item 
 
Lloyd-Williams et al, 2001121 UK 100 56 57 Cancer HADS-D 
 
Lloyd-Williams et al, 2004122 UK 74 37 68 Cancer 1-item 
      
EPDS 
 
Love et al, 2002123 Australia 303 303 Not reported Cancer HADS-D 
 
Study Country Patients Female 
Mean age, 
years 
Physical health condition Instrument 
Love et al, 2004124 Australia 227 227 52 Breast cancer HADS 
      
BDI non-somatic 
 
Low et al, 2007125 Canada 119 30 63 
Myocardial infarction or 
angina 
BDI 
      
GDS 
 
Lowe et al, 2004126 Germany 501 167 42 Medically ill (general medical) HADS-D 
      
PHQ-9 
      
PHQ-2 
 
Lustman et al, 1997127 US 172 83 48 Diabetes BDI 
 
Lykouras et al, 1996128 Greece 107 57 43 Neurological disorder GHQ-28 
 
Magni et al,1986129 Italy 220 109 76 Medically ill (general medical) GDS 
 
McManus et al, 2005130 US 1024 184 67 Chronic heart disease PHQ-9 
      
PHQ-2 
      
Two stem questions 
      
CES-D 
 
McQuillan et al,2003131 US 415 344 58 Rheumatoid Arthritis CES-D 
 
Meyer et al, 2003132 US 45 
Not 
reported 
Not reported Cancer 1-item 
 
Mitchell et al, 2008133 UK 129 
Not 
reported 
58 Cancer PHQ-2 
      
1-item 
 
Mohr et al, 2007134 US 260 190 51 Multiple sclerosis Two stem questions 
      
1-item 
 
Narding et al, 2002135 Netherlands 44 16 70 Stroke HDRS 
 
Neal et al, 1994136 UK 45 28 77 Medically ill (general medical) GDS 
      
GDS-15 
 
O'Rourke et al, 1998137 UK 105 
Not 
reported 
68 Stroke HADS-D 
 
Okimoto et al, 1982138 Japan 55 
Not 
reported 
Not reported Medically ill (general medical) Zung 
 
Olden et al, 2009139 US 439 239 66 Cancer HDRS 
 
Ozalp et al, 2008140 Turkey 208 208 51 Cancer HADS-D 
 
Parikh et al, 1988141 US 80 40 58 Stroke CES-D 
 
Parker et al, 2002142 Australia 302 175 47 Medically ill (general medical) HADS-D 
      
BDI non-somatic 
 
Passik et al, 2001143 US 60 58 31 Cancer Zung 
 
Patterson et al, 2006144 US 310 37 40 HIV BDI non-somatic 
Study Country Patients Female 
Mean age, 
years 
Physical health condition Instrument 
 
Payne et al, 2007145 US 167 
Not 
reported 
Not reported Cancer Two stem questions 
      
1-item 
 
Persoons et al, 2003146 Netherlands 97 64 48 Otolaryngology PHQ-9 
 
Picardi et al, 2005147 Italy 141 79 38 Dermatology GHQ-12 
      
PHQ-9 
 
Pomeroy et al, 2001148 US 87 52 78 Medically ill (general medical) GDS 
      
GDS-15 
      
1-item 
 
Poole et al, 2006149 US 115 47 43 Heart disease HADS-D 
 
Rapp et al, 1988150 US 150 48 69 Medically ill (general medical) GDS 
      
BDI 
 
Razavi et al, 1990151 Belgium 210 140 55 Cancer HADS-D 
 
Reuter and Harter, 2000152 Germany 188 51 54 Cancer HADS-D 
      
GHQ-12 
 
Rinaldi et al, 2003153 US 181 
Not 
reported 
79 Medically ill (general medical) GDS-15 
 
Roger et al, 2009154 US 67 35 71 Stroke CES-D 
      
HDRS 
      
GDS-15 
 
Rovner et al, 1997155 US 70 41 77 Visual impairment GDS 
 
Sagen et al, 2009156 Norway 104 43 65 Stroke HADS-D 
      
MADRS 
 
Scheinthal et al, 2001157 US 75 42 74 Medically ill (general medical) GDS-15 
      
BDI non-somatic 
 
Schein et al, 1997158 US 76 35 70 Medically ill (general medical) CES-D 
 
Serrano-Duenas et al, 
2008159 
Ecuador 115 33 70 Parkinson's disease HDRS 
 
Shinar et al, 1986160 Israel 27 16 56 Stroke CES-D 
 
Silberman et al, 2006161 Brazil 46 19 68 Parkinson's disease MADRS 
      
BDI 
 
Singer et al, 2008162 Germany 250 23 Not reported Cancer HADS-D 
 
Sivrioglu et al, 2009163 Turkey 85 53 59 Stroke GDS 
 
Stafford et al, 2007164 Australia 193 39 64 Heart disease HADS-D 
      
PHQ-9 
 
Strik et al, 2001165 US 206 49 59 Myocardial infarction HADS-D 
Study Country Patients Female 
Mean age, 
years 
Physical health condition Instrument 
      
HDRS 
      
BDI 
 
Tang et al, 2004166 China 100 45 74 Stroke GDS 
      
HADS-D 
      
GDS-15 
 
Tang et al, 2004167 China 60 
Not 
reported 
Not reported Stroke GDS 
      
HADS-D 
 
Thekkumpurath et al, 2009168 UK 150 86 70 Cancer GHQ-12 
 
Turner et al, 1984169 US 40 20 47 Chronic pain Zung 
      
BDI 
      
BDI-non somatic 
 
Upadhyaya et al, 1997170 UK 72 35 71 Medically ill (general medical) HADS-D 
 
Vahter et al, 2007171 Estonia 134 
Not 
reported 
44 Multiple sclerosis 1-item 
 
Vargas et al, 2007172 Portugal 484 276 70 Medically ill (general medical) GDS 
 
Walker et al, 2007173 UK 361 238 Not reported Cancer HADS-D 
 
Watnick et al, 2005174 US 62 20 63 Dialysis PHQ-9 
      
BDI 
 
Weintraub et al, 2006175 US 148 
Not 
reported 
71 Parkinson's disease GDS-15 
      
HDRS 
 
Wilhelm et al, 2004176 Australia 212 117 Not reported Medically ill (general medical) BDI non-somatic 
 
Williams et al, 2005177 US 296 219 59 Stroke PHQ-2 
      
PHQ-9 
Notes 
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